October 26, 2021 • 12:00 PM - 3:00 PM ET

A variety of activity and attention continues to surround the 340B Drug Pricing Program and its key stakeholders. This webinar series, now in its 4th iteration, examines the most pressing issues impacting those directly involved with 340B efforts at their organization. Continue the conversation for and between covered entities and manufacturers with insight around the potential legislative, regulatory, judicial, and business activities affecting the program, including the continuing dispute around contract pharmacy arrangements, and best practices for covered entities to ensure program integrity and compliance and maximize savings.

Webinar Agenda:

12:00 – 1:00 pm

A View from Washington: Recent Legislative, Policy, and Industry Updates Surrounding 340B
This opening session looks at the most recent developments impacting the 340B Drug Pricing Program and its key stakeholders. Our panel evaluates the latest political, legislative, judicial, and business developments and gives insight into what covered entities, HRSA grantees, pharmacies, distributors, and manufacturers should stay abreast of.

  • Gain insight around the current drug pricing debate in Congress, impact to 340B
  • Hear the latest news surrounding contract pharmacy
    • Discuss what may be expected from the courts, regulatory agencies, and Congress
  • Explore the latest 340B specific legislative activity
    • Federal:  Drug pricing amendments, PROTECT Act, hospital transparency, DSH eligibility
    • State:  Discriminatory Reimbursement, contract pharmacy (Arkansas law)
  • Examine continuing activity around Medicare Part B payments to 340B hospitals
    • Consider implications of the CMS OPPS Final Rule
    • Learn what the US Supreme Court may consider when it hears the case in November
Michael McCaughan
Michael McCaughan
The RPM Report
View Bio
Ted Slafsky
Ted Slafsky
Publisher and CEO
340B Report
View Bio
Peggy Tighe
Peggy Tighe, JD
Powers Pyles Sutter & Verville PC
View Bio

1:00 – 2:00 pm

Ensure Compliance and Maximize Savings Using These Essential Reports
There are a variety of reports that covered entities can generate. During this session, learn about five practical reports that use analytics to verify accuracy of data, maximize savings, and most importantly ensure compliance.

  • Identify the most valuable reports to monitor your program and recommended timing to run them
    • Understand the purpose of each report, reason it’s important, and action plan that should be taken with its findings
  • Learn about other important 340B data checks
  • See a sample of one hospital’s report schedule and hear first-hand about its experiences using them
Ambre Ayoub
Ambre Ayoub
340B Pharmacy Compliance Analyst
Seattle Children’s Hospital
View Bio
Larry Crowder
Larry Crowder
Director, 340B Solutions
View Bio

2:00 – 3:00 pm

Optimize Your 340B Efforts by Creating a Referral Prescription Capture Program
Establishing a referral prescription capture program enables covered entities to broaden the reach of their 340B Drug Discount Program by ensuring patients are retained by the covered entity when they utilize specialists who are outside of their physician network.

  • Discuss 340B program optimization efforts, including how covered entities can get the most from their referral capture efforts
  • Hear the details of how one health system captured more than $1 million during an eight-month period
Todd Hudnall
Todd Hudnall
Vice President, 340B Solutions
View Bio
Dennis Killian
Dennis Killian
Senior Consultant
View Bio


General Inquiries:

World Congress Customer Relations
Phone: 781-939-2400
Toll-free: 800-767-9499
Email: wcreg@worldcongress.com

Receive Email Updates

Be the first to learn about our upcoming events, promotions and news.